ABPI have been denied the opportunity to legally challenge incorporation of the £20 million budget impact test being incorporated into NICE assessments.
ABPI have been denied the opportunity to legally challenge incorporation of the £20 million budget impact test being incorporated into NICE assessments.
Joint Clinical Assessment (JCA) provides a common EU-level clinical assessment, but national HTA and...
Read moreManufacturers should not wait for final HTA scopes to test whether their evidence package can addres...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch